Product Information

CLINDAMYCIN PH 1% GEL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1475 per GM under NDC 45802090094. Its NADAC has been published 297 times since Mar 10, 2021.

FDA first approved this application on Dec 31, 2020. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN PH 1% GEL

clindamycin phosphate
$0.1475per GM

Strength

10 mg/g

NDC

45802090094

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

CLINDAMYCIN PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212104

FDA Approved

12/31/2020

TE Code

AB1

On Market Since

1/20/2021

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN PH 1% GEL has been published 297 times since Mar 10, 2021, and over the history we have for it it has declined 86.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1475 per GM
All-time high$1.1292 (Apr 14, 2021)
All-time low$0.1372 (Jul 22, 2026)
52-week high$0.1599
52-week low$0.1372
Median price$0.3645
Average price$0.4112
Largest weekly change-40.7% (Oct 23, 2024)
Weeks tracked297
Tracking sinceMar 10, 2021

Price History

1W

0.0%

1M

+3.6%

3M

+7.5%

6M

+5.8%

1Y

-3.4%

3Y

-61.3%

5Y

-83.2%

All

-86.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN PH 1% GEL?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PH 1% GEL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1475 per GM (NDC 45802090094), effective Nov 11, 2026.

How has the price of CLINDAMYCIN PH 1% GEL changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN PH 1% GEL has declined 86.6%. It has been tracked across 297 weekly CMS publications since Mar 10, 2021.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PH 1% GEL?

Since Mar 10, 2021, the NADAC for CLINDAMYCIN PH 1% GEL has ranged from a low of $0.1372 (Jul 22, 2026) to a high of $1.1292 (Apr 14, 2021), with a median of $0.3645 per GM.

Are there cheaper alternatives to CLINDAMYCIN PH 1% GEL?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN PH 1% GEL, is $0.1362 per GM — about 8% below CLINDAMYCIN PH 1% GEL.

Who manufactures CLINDAMYCIN PH 1% GEL?

CLINDAMYCIN PH 1% GEL (NDC 45802090094) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.